Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-20-044748

Chief Business Officer sold 11,110 shares at $47.65 ($529,404)

  • Chief Business Officer acquired 11,110 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Parrish Jay Chief Business Officer 2020-08-03 Option exercise +9,259 $1.49 $13,750 231,481 D
Parrish Jay Chief Business Officer 2020-08-03 Option exercise +1,851 $1.58 $2,915 233,332 D
Parrish Jay Chief Business Officer 2020-08-03 Sale −11,110 $47.65 $529,404 222,222 D
Derivatives
Parrish Jay Chief Business Officer 2020-08-03 Option exercise · Stock Option (Right to Buy) −9,259 37,037 D
Parrish Jay Chief Business Officer 2020-08-03 Option exercise · Stock Option (Right to Buy) −1,851 60,184 D
Open-market sales · 11,110 sh · avg $47.65 · $529,404
Loading xslF345X03/doc4.xml…